Skip to main content

Practice Management

Practice Management

Induction Therapy plus Autologous Stem-Cell Transplantation Still Cost-Effective for Newly Diagnosed Multiple Myeloma

Practice Management

The Impact of Policy and Politics on Health and Drug Pricing

Practice Management

Leveraging Real-World Evidence in Disease-Management Decision-Making with a Total Cost of Care Estimator

Thanh-Nghia Nguyen, DrPH, MPH, MBA, Jeffrey Trocio, MPH, Stacey Kowal, MS, Cheryl P. Ferrufino, Julie Munakata, MS, Dell South, PharmD

Stakeholder Perspective

Hypothesis Generation: An Essential Component of Informed Healthcare Management

by Michael F. Murphy, MD, PhD

Practice Management

Bundled Payments: Value-Based Care Implications for Providers, Payers, and Patients

Byron C. Scott, MD, MBA, Tricia L. Eminger, MPH

Practice Management

Use of the Prostate Core Mitomic Test in Repeated Biopsy Decision-Making: Real-World Assessment of Clinical Utility in a Multicenter Patient Population

Lorena Legisi, MPH, Elise DeSa, HBSc, M. Nasar Qureshi, MD, PhD

Stakeholder Perspective

Molecular Tests May Aid Clinical Decision-Making and Reduce Healthcare Costs

by Kelly Huang, PhD

Practice Management

Healthcare Spending: Plenty of Blame to Go Around

Gary Branning, MBA, Martha Vater

Practice Management

Effects of Specialty Pharmacy Care on Health Outcomes in Multiple Sclerosis

Jun Tang, PhD, James Bailey, MD, MPH, Cyril Chang, PhD, Richard Faris, PhD, Song Hee Hong, PhD, Michael Levin, MD, Junling Wang, PhD

Stakeholder Perspective

What Makes Specialty Pharmacy Care So Special?

by Atheer A. Kaddis, PharmD

Practice Management

Examining the Value of Subsidies of Health Plans and Cost-Sharing for Prescription Drugs in the Health Insurance Marketplace

Surachat Ngorsuraches, PhD, Jane R. Mort, PharmD

Stakeholder Perspective

Health Plan Subsidies, Prescription Drugs, and Cost

by Byron C. Scott, MD, MBA

Practice Management

Revealed Opportunism: How Physicians “Game” Prior Authorization Protocols Until They Are Rescinded

Natan R. Kahan, RPh, MHA, PhD, Dan-Andrei Waitman, MD, MPH, David P. Chinitz, PhD

Stakeholder Perspective

A Matter of Trust

by Albert Tzeel, MD, MHSA, CPE, FAAPL

Practice Management

Employer Perspectives on a Specialty Drug Step-Therapy Program Evaluation

Matthew Harman, PharmD, MPH, F. Randy Vogenberg, PhD, FASHP

Page 12 of 32
Results 111 - 120 of 318